Home > PRESCRIPTION >

Equioxx (firocoxib) Oral Paste for Horses, 6.93 g

Equioxx l Arthritis Treatment For Horses


 
Alternative Views:


Sold ONLY to licensed veterinarians and pharmacies. Submit license if not already on file. Fax :: 800-640-3274
Licensed Professional Price: $4.43
Rx:
Copy of License Required [No Prescriptions Please]

Stock Status:In Stock


Product Code: 16571
Qty:

Description
 

Equioxx Oral Paste for Horses

Firocoxib

Equioxx Oral Paste -Merial is a non-steroidal anti-inflammatory drug for the control of pain and inflammation associated with osteoarthritis in horses. Each syringe contains 6.93 grams of Firocoxib and will treat a 1250 lb horse. Give once daily for 14 days.

Firocoxib belongs to the coxib class of non-narcotic, non-steroidal anti-inflammatory drugs (NSAID) with analgesic and antipyretic activity.

Dosage and Administration:

The recommended dosage of EQUIOXX (firocoxib) for oral administration in horses is 0.045 mg/lb (0.1 mg/kg) of body weight once daily for up to 14 days.

Each marking on the syringe will treat 250 pounds of body weight, and each notch corresponds to approximately a 50 Ib weight increment. To deliver the correct dose, round the horse's body weight up to the nearest 50 pound increment (if the body weight is an exact 50 pound increment, do not round up). Unlock the knurled ring on the syringe plunger by rotating it 1/4 turn. Slide the knurled ring along the plunger shaft so that the side nearest the barrel is at the appropriate 50 Ib weight notch. Rotate the plunger ring 1/4 turn to lock it in place and ensure it is locked.

EQUIOXX may be given with or without food.

Contraindications:

Horses with hypersensitivity to firocoxib or other NSAIDs should not receive EQUIOXX Oral Paste.

Warnings:

For oral use in horses only. Do not use in horses intended for human consumption.

Precautions:

Treatment with EQUIOXX should be terminated if signs such as inappetance, colic, abnormal feces, or lethargy are observed.

As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal and gastrointestinal toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Patients at greatest risk for adverse events are those that are dehydrated, on diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached or avoided. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since many NSAIDs possess the potential to produce gastrointestinal ulcerations, concomitant use with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided or closely monitored. The concomitant use of protein bound drugs with EQUIOXX Oral Paste has not been studied in horses. The influence of concomitant drugs that may inhibit the metabolism of EQUIOXX Oral Paste has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy.

The safe use of EQUIOXX Oral Paste in horses less than one year in age, horses used for breeding, or in pregnant or lactating mares has not been evaluated.

Consider appropriate washout times when switching from one NSAID to another NSAID or corticosteroid.

EQUIOXX (firocoxib) Oral Paste was safely used concomitantly with other therapies, including vaccines, anthelmintics, and antibiotics, during the field studies.

Adverse Reactions:

Adverse reactions may include erosions and ulcers of the gums, tongue, lips and face, weight loss, colic, diarrhea, or icterus. Serious adverse reactions associated with this drug class can occur without warning and, in rare situations, result in death. Horse Owners should be advised to discontinue NSAID therapy and contact their veterinarian immediately if any of these signs of intolerance are observed. The majority of patients with drug-related adverse reactions recover when the signs are recognized, drug administration is stopped, and veterinary care is initiated.

Federal law restricts this drug to use by or on the order of a licensed veterinarian

Store below 86°F (30°C). Brief excursions up to 104°F (40°C) are permitted.

Rx Medication Sold Only To Licensed Veterinarians & Pharmacies. Current License Must Be On File Prior To Shipping.


Share your knowledge of this product. Be the first to write a review »